Clinical Research Fellowship (100%)

About the job

The EOC the multisite hospital of Ticino is present with its institutions on the entire cantonal territory with a total of 1,000 beds. The organization makes it possible to effectively combine local approach and overall vision, guaranteeing the population a comprehensive and proximity hospital offer, regardless of where services are required.

Thanks to the commitment and expertise of its more than 6,500 employees and their focus on human relationships, the EOC ensures quality health care by caring for more than 41,000 patients a year and providing more than 600,000 ambulatory consultations.

To complete the team at the Oncological Institute of Southern Switzerland (IOSI) Bellinzona, Clinical Research Unit and Phase 1 Program, we are looking for a/an

Clinical Research Fellowship (100%)

The Oncology Institute of Southern Switzerland is one of the largest clinical research centers in Switzerland. Our three main areas of clinical research comprise new drug development, lymphoproliferative diseases and prostate cancer. Other important areas of development in clinical research include gynecological, breast, lung, skin and gastrointestinal cancer.

The IOSI has a dedicated phase 1 unit where early phase clinical trials, including first-in-human, are conducted. We have an excellent history of collaborating with both non-for-profit academic organizations and the pharmaceutical industry. Of particular relevance are our collaborations with the Institute of Oncology Research (IOR), the Institute of Biochemical Research (IRB) and the Swiss Cancer Institute (SCI, ex SAKK). We have a central role in the Faculty of Biomedical Sciences of the Università della Svizzera Italiana (USI).

We are offering a Clinical Research Fellowship in Drug Development in solid tumors. This fellowship would incorporate activities in the Phase 1 Unit of the IOSI and clinical activity in solid tumors. During the fellowship program, there will be the possibility to participate in educational activities performed in our institute and selected external events.

Through this fellowship, you will develop your clinical skills, increase your knowledge on how to conduct clinical research and manage patients enrolled in clinical trials, particularly focusing on early phase clinical trials.

A minimum commitment of one year is required, to allow you to complete the fellowship objectives.

Job Summary/Objectives:

• Develop clinical expertise in the management of patients with solid tumors enrolled in early phase clinical trials
• Learn the different aspects of the clinical research, particularly regarding trial design, evaluation of treatment toxicity and efficacy, management of patients enrolled in clinical trials, with a focus on early phase clinical trials of novel therapeutics
• Participation in study-specific safety calls in collaboration with the Principal Investigator and the Clinical Research Unit (CRU) team
• Attend internal meetings and educational activities
• Partecipate in multidisciplinary tumour boards
• Participation in research projects with clinical or translational objectives
• Conceptualize and conduct at least one specific research project that is realizable within the period of the fellowship
• Publish manuscripts in peer-reviewed journals

Candidates must be/have:

• A degree in Medicine
• Experience in Medical Oncology of at least 2 years
• Proficient in Italian for patients and clinical activities, minimum B2 level (if non-native Italian speaker)
• Proficient in English, as this is the primary language of research and related communications

The per annum rate is approximately 40’000 CHF, the Swiss mandatory health insurance costs will be deducted from this before payment to the post holder. Candidates receiving a grant from their institution or from a national or international society, will instead have their grant topped up to this level. Travel and accommodation costs are considered as included in this salary and there will be no additional payments made.

Timeline:

The start of the fellowship is planned from December 2026, but a case by case discussion can also be considered

You should also verify your eligibility for registering with (MEBEKO). However, we recommend you do not apply to register with MEBEKO at this point.

For more information you can write to the e-mail adress: E-Mail schreiben, E-Mail schreiben. No paper applications will be accepted.